Meet the Team
Chief Executive Officer
Joseph is focused on optimizing the translational value of CanCog's services to facilitate the development and approval of novel drugs. Joseph continues to be closely involved in projects utilizing, characterizing and developing the aged dog as a natural model of age-related human diseases.
Joseph is a strong proponent for the use of validated natural and/or translational animal models in drug discovery.
Veterinary Scientific Director
Dr. Landsberg is a board-certified veterinary behaviorist, author of numerous veterinary behavior publications, and a frequent international invited speaker. He is a diplomate of both the American College of Veterinary Behaviorists and the European College of Animal Welfare and Behavioural Medicine, and has been a veterinary practitioner and veterinary behaviorist in his own practices for over 40 years.
Dr. Landsberg has authored and edited clinical textbooks in veterinary behavior including Behavior Problems of the Dog and Cat, and Canine and Feline Dementia, and has published and presented over 40 research studies primarily in the field of canine and feline fear and anxiety, brain aging and cognitive dysfunction. As scientific veterinary director, Dr. Landsberg aids in the development of models for canine and feline behavior disorders and serves as project consultant and scientific advisor for therapeutic trials.
Chairman of the Board
Dr. Milgram is a co-founder of CanCog and the world's leading expert in the field of canine cognitive aging. Dr. Milgram has a Ph.D in behavioral neuroscience from McGill University and is a professor emeritus at the University of Toronto, having had appointments in the Departments of Psychology, Pharmacology and Medical Sciences.
His scientific record include over 150 peer reviewed publications, over 100 abstracts, 2 edited books and 8 book chapters. He has also been a consultant to several animal health and pet food companies.
Christina de Rivera
Chief Scientific Officer
Christina has been with the company since its inception in 2005 and is currently the Chief Scientific Officer for all Canine work conducted by the business.
Christina brings a breadth of operational experience having run all aspects of the research laboratory, together with a deep knowledge of Canine physiology and pharmacology.
Christina's personal scientific interests are in finding new medications to alleviate canine diseases of ageing, together with anxiety and stress. This has followed her pursuit of a PhD in the laboratory of Prof. Bill Milgram (University of Toronto), investigating the use of non-invasive imaging technologies to study brain aging.
Senior Scientific Director
As Senior Scientific Director, Stephanie has 12 + years experience coordinating and managing pre-clinical trials in human and animal health with focus in dog cognition and aging, behaviour and diabetes.
Stephanie brings extensive operational experience having spent the first eight years of her career as a study coordinator/research technician with CanCog, mastering operational and scientific aspects of research conduct while contributing to the development of many of the canine models utilized today. Stephanie also brings expertise from the clinical research field, with a background in clinical trial conduct and experience conducting veterinary field trials.
In addition to her primary function as Scientific Director, Stephanie is dedicated to promoting animal health and welfare within contract research settings.
Whitney has over 10 years of experience overseeing scientific trials related to animal and human health. Whitney’s experience lies within the companion animal department, where she has developed experience in a variety of pre-clinical proof of concept studies as well as efficacy, pharmacokinetics and model development in the areas of behaviours related to anxiety and stress, pain associated with mobility, periodontal disease and dermatology in canines and felines.
As a Scientific Director, Whitney is proficient in developing, implementing and managing model development, study designs and data interpretation. Whitney currently functions as one of the scientists on our internal Animal Care Committee and is dedicated to helping improve the quality of life of companion animals through the advancements of science and technology.
Associate Scientific Director
For Anand, improvement of health outcomes is more than a passion. He holds 6+ years of preclinical (Tox/PK/PD), biochemistry and molecular biology experience to advance health through science.
Anand earned his M.Sc. in Parasitology (specialization in biochemistry) from McGill University. Having worked with both small (Rodents) and large animal models (Canine & Non-Human Primates), he take a multidisciplinary in-vitro and in-vivo approach to investigate new drug targets. He is passionate about surgical model development to establish an efficient drug delivery system for acute and chronic disease models. Being versatile, he enjoys working from the many angles of a project and liaising between teams and development.
Associate Scientific Director
Andrea is responsible for the management and integrity of the design, conduct, and reporting of research projects. Andrea’s educational background focused on psychology and she has been working in the field of animal research for 8+ years.
Andrea has extensive experience with all of our translational models in relation to companion animals, and has been instrumental in the development and refinement of our diabetic model in particular. As a member of our Animal Care Committee she works to ensure the highest standards of animal ethics and care are valued and assured in each project we conduct.